Health-related quality of life among children with acute lymphoblastic leukemia

Pediatric Blood & Cancer, 04/27/2012

Patients with acute lymphoblastic leukemia (ALL) experienced important but declining deficits in health–related quality of life (HRQL) during active treatment phases: Equivalent to losing approximately 2 months of life in perfect health. HRQL within the 2–years post–treatment phase was similar to controls. The policy challenge is to develop new treatment protocols producing fewer disabilities in mobility/ambulation, emotion, self–care, and pain without compromising survival.

Print Article Summary Cat 2 CME Report